- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-06-0003408

Uttranchal Pharmaceuticals Private Limited
About Uttranchal Pharmaceuticals Private Limited
Data last updated:
Uttranchal Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 July 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC138489. Its GSTIN is 05AAACU8590L1ZU (Uttarakhand).
The company has an authorised share capital of ₹2.15 Cr and a paid-up capital of ₹2.15 Cr. It is led by directors Kathiravanathan (Managing Director) and Nitha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 737 Gali No.24 Sant Nagar Burari, New Delhi, Delhi, India – 110084.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.94 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹5.29 Lakh (net margin 1.1%) and EBITDA of ₹45.64 Lakh (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹8.35 Cr and satisfied charges of ₹5.05 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Uttranchal Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0003408). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Uttranchal Pharmaceuticals
Contact details
Uttranchal Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 737 Gali No.24 Sant Nagar Burari, New Delhi, Delhi, India – 110084
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Uttranchal Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Uttranchal Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Uttranchal Pharmaceuticals Private Limited, buy the company report.
Financials of Uttranchal Pharmaceuticals Private Limited
FY 2025 filings availableUttranchal Pharmaceuticals Private Limited reported revenue of ₹4.94 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 2% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.29 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Uttranchal Pharmaceuticals Private Limited, buy the company report.
Board of directors of Uttranchal Pharmaceuticals Private Limited
Uttranchal Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kathiravanathan | Managing Director | 20 Jan 2015 | 11 Years 9 Months | Current |
| Nitha | Director | 20 Jan 2015 | 11 Years 9 Months | Current |
Peer comparison
Uttranchal Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| NRJ Pharmachem Private Limited | ₹4.95 Cr (FY 2025) | 47.0% | Navi Mumbai, Maharashtra, India | |||
| Elikem Nutra Private Limited | ₹4.95 Cr (FY 2025) | 92.0% | Rakanpur, Gujarat, India | |||
| Uttranchal Pharmaceuticals Private Limitedthis company | ₹4.94 Cr (FY 2025) | ₹5.29 Lakh | 1.1% | 2.0% | New Delhi, Delhi, India | |
| Lewis Bioserch Pharma Private Limited | ₹4.94 Cr (FY 2024) | 19.0% | Chandigarh, India | |||
| Cataliq Laboratories Private Limited | ₹4.94 Cr (FY 2024) | -12.0% | Ahmedabad, Gujarat, India | |||
| Karlin Pharmaceuticals & Exports Private Limited | ₹4.93 Cr (FY 2025) | 12.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Uttranchal Pharmaceuticals Private Limited, buy the company report.
Auditor
Uttranchal Pharmaceuticals Private Limited is audited by SINGH AMIT & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGH AMIT & ASSOCIATES | FY 2024 | 019157C |
Shareholding
The shareholding of Uttranchal Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2017 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Uttranchal Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 May 2025 | 101112591 | Others | ₹8.35 Cr | Open | |
| 27 May 2023 | 100730026 | Axis Bank Limited | ₹2.7 Cr | Satisfied | |
| 17 May 2022 | 100576801 | Hdfc Bank Limited | ₹1.42 Cr | Satisfied | |
| 16 Jun 2020 | 100360681 | Others | ₹13.12 Lakh | Satisfied | |
| 15 Apr 2015 | 10568692 | Punjab National Bank | ₹80 Lakh | Satisfied |
To see the full charge records of Uttranchal Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Uttranchal Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pudukkottai, Tamil Nadu | Criminal case | Filed against the company by an individual | Disposed |
To see the full case history of Uttranchal Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uttranchal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Uttranchal Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACU8590L1ZU | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Uttranchal Pharmaceuticals Private Limited, buy the company report.
Recent activity
Uttranchal Pharmaceuticals Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Suresh Kumar Khurana ceased to be Director on 24 Feb 2015.
6 earlier events are in the company report.
Frequently asked questions
Uttranchal Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 July 2005 (21+ years old) and is registered under CIN U24232DL2005PTC138489.
Uttranchal Pharmaceuticals has 2 current directors:
- Kathiravanathan - Managing Director
- Nitha - Director
The latest financial statements of Uttranchal Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Uttranchal Pharmaceuticals is 05AAACU8590L1ZU, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Uttranchal Pharmaceuticals is U24232DL2005PTC138489. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uttranchal Pharmaceuticals has 1 court case on record: 1 filed against it.
Uttranchal Pharmaceuticals was incorporated on 08 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Uttranchal Pharmaceuticals by revenue are NRJ Pharmachem Private Limited, Elikem Nutra Private Limited, Lewis Bioserch Pharma Private Limited, Cataliq Laboratories Private Limited, Karlin Pharmaceuticals & Exports Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Suresh Kumar Khurana ceased to be Director on 24 Feb 2015. Harish Nangia ceased to be Director on 09 Feb 2015. Krishan Kumar Nangia ceased to be Director on 09 Feb 2015. Uttranchal Pharmaceuticals has 6 board changes on record in total.
Yes, Uttranchal Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0003408).
The registered office of Uttranchal Pharmaceuticals is at B – 737 Gali No.24 Sant Nagar Burari, New Delhi, Delhi, India – 110084.

